373 related articles for article (PubMed ID: 19669997)
21. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
[TBL] [Abstract][Full Text] [Related]
23. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
Kinemuchi H; Arai Y; Toyoshima Y
Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Fuller RW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Castagnoli K; Palmer S; Castagnoli N
Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
Thomas B; Saravanan KS; Mohanakumar KP
Neurochem Int; 2008 May; 52(6):990-1001. PubMed ID: 18164516
[TBL] [Abstract][Full Text] [Related]
27. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
29. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
Di Monte DA; Schipper HM; Hetts S; Langston JW
Glia; 1995 Oct; 15(2):203-6. PubMed ID: 8567072
[TBL] [Abstract][Full Text] [Related]
30. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.
Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227
[TBL] [Abstract][Full Text] [Related]
32. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation.
Hiebert CK; Sayre LM; Silverman RB
J Biol Chem; 1989 Dec; 264(36):21516-21. PubMed ID: 2600079
[TBL] [Abstract][Full Text] [Related]
35. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
Trevor AJ; Singer TP; Ramsay RR; Castagnoli N
J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
Di Monte DA; Royland JE; Anderson A; Castagnoli K; Castagnoli N; Langston JW
J Neurochem; 1997 Oct; 69(4):1771-3. PubMed ID: 9326308
[TBL] [Abstract][Full Text] [Related]
37. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Castagnoli K; Palmer S; Anderson A; Bueters T; Castagnoli N
Chem Res Toxicol; 1997 Apr; 10(4):364-8. PubMed ID: 9114971
[TBL] [Abstract][Full Text] [Related]
38. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.
Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N
Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730
[TBL] [Abstract][Full Text] [Related]
39. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
Shi H; Noguchi N; Xu Y; Niki E
FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696
[TBL] [Abstract][Full Text] [Related]
40. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]